[HTML] mdpi.com

[HTML][HTML] Multifocal signal modulation therapy by celecoxib: A strategy for managing castration-resistant prostate cancer

R Benelli, P Barboro, D Costa, S Astigiano… - International Journal of …, 2019 - mdpi.com
Background: Prostate cancer (PCa) is a significant health concern throughout the world.
Standard therapy for advanced disease consists of anti-androgens, however, almost all …
被引用次数：10 相关文章

Multifocal Signal Modulation Therapy by Celecoxib: A Strategy for Managing Castration-Resistant Prostate Cancer.

R Benelli, P Barboro, D Costa, S Astigiano… - … Journal of Molecular …, 2019 - europepmc.org
Background: Prostate cancer (PCa) is a significant health concern throughout the world.
Standard therapy for advanced disease consists of anti-androgens, however, almost all …

Multifocal Signal Modulation Therapy by Celecoxib: A Strategy for Managing Castration-Resistant Prostate Cancer

R Benelli, P Barboro, D Costa, S Astigiano, O Barbieri… - agris.fao.org
Background: Prostate cancer (PCa) is a significant health concern throughout the world.
Standard therapy for advanced disease consists of anti-androgens, however, almost all …

Multifocal Signal Modulation Therapy by Celecoxib: A Strategy for Managing Castration-Resistant Prostate Cancer

R Benelli, P Barboro, D Costa… - International …, 2019 - search.proquest.com
Background: Prostate cancer (PCa) is a significant health concern throughout the world.
Standard therapy for advanced disease consists of anti-androgens, however, almost all …

Multifocal Signal Modulation Therapy by Celecoxib: A Strategy for Managing Castration-Resistant Prostate Cancer.

R Benelli, P Barboro, D Costa… - International …, 2019 - search.ebscohost.com
Abstract Background: Prostate cancer (PCa) is a significant health concern throughout the
world. Standard therapy for advanced disease consists of anti-androgens, however, almost …
[HTML] nih.gov

[HTML][HTML] Multifocal Signal Modulation Therapy by Celecoxib: A Strategy for Managing Castration-Resistant Prostate Cancer

R Benelli, P Barboro, D Costa, S Astigiano… - … Journal of Molecular …, 2019 - ncbi.nlm.nih.gov
Background: Prostate cancer (PCa) is a significant health concern throughout the world.
Standard therapy for advanced disease consists of anti-androgens, however, almost all …
[PDF] semanticscholar.org

[PDF][PDF] Multifocal Signal Modulation Therapy by Celecoxib: A Strategy for Managing Castration-Resistant Prostate Cancer

R Benelli, P Barboro, D Costa, S Astigiano… - Int. J. Mol …, 2019 - pdfs.semanticscholar.org
Background: Prostate cancer (PCa) is a significant health concern throughout the world.
Standard therapy for advanced disease consists of anti-androgens, however, almost all …
[PDF] scienceopen.com

[PDF][PDF] Multifocal Signal Modulation Therapy by Celecoxib: A Strategy for Managing Castration-Resistant Prostate Cancer

R Benelli, P Barboro, D Costa, S Astigiano… - Int. J. Mol …, 2019 - scienceopen.com
Background: Prostate cancer (PCa) is a significant health concern throughout the world.
Standard therapy for advanced disease consists of anti-androgens, however, almost all …

Multifocal Signal Modulation Therapy by Celecoxib: A Strategy for Managing Castration-Resistant Prostate Cancer

R Benelli, P Barboro, D Costa, S Astigiano… - International Journal of …, 2019 - cir.nii.ac.jp
抄録< jats: p> Background: Prostate cancer (PCa) is a significant health concern throughout
the world. Standard therapy for advanced disease consists of anti-androgens, however …

Multifocal Signal Modulation Therapy by Celecoxib: A Strategy for Managing Castration-Resistant Prostate Cancer

R Benelli, P Barboro, D Costa… - International …, 2019 - pubmed.ncbi.nlm.nih.gov
Background Prostate cancer (PCa) is a significant health concern throughout the world.
Standard therapy for advanced disease consists of anti-androgens, however, almost all …